Rexnord Corporation (NYSE:RXN)(“Rexnord”) announced today the pricing of the previously announced public offering of its common stock. Rexnord will issue and sell 3,000,000 shares of its common stock and certain funds affiliated with Apollo Global Management, LLC (collectively with its subsidiaries, “Apollo”) (NYSE:APO) and George M. Sherman, Chairman of the Board of Directors of Rexnord, and certain of his affiliates (together with Apollo, the “Selling Stockholders”), will sell 12,000,000 shares of Rexnord common stock at a price to the public of $25.75 per share. The Selling Stockholders have also granted to the underwriters of the common stock offering an option to purchase up to an additional 2,250,000 shares of common stock. Rexnord intends to use the net proceeds from the sale of shares by it in the offering for general corporate purposes. Rexnord will not receive any proceeds from the sale of the shares by the Selling Stockholders in the offering. The offering is expected to close on or about February 5, 2014, subject to certain customary closing conditions. The offering is being made under Rexnord’s registration statement as filed with the Securities and Exchange Commission. Goldman, Sachs & Co., Baird and Credit Suisse are bookrunners for the offering, BofA Merrill Lynch, Barclays, BMO Capital Markets and Deutsche Bank Securities are also bookrunners and Apollo Global Securities is the co-manager. This press release does not constitute an offer to sell or a solicitation of an offer to buy these securities, nor does it constitute an offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale is unlawful. The offering may be made only by means of a prospectus and a related prospectus supplement, copies of which may be obtained from Goldman, Sachs & Co., Attn: Prospectus Department, 200 West Street, New York, New York 10282, (866) 471-2526, Robert W. Baird & Co. Incorporated, Attn: Syndicate Department, 777 East Wisconsin Avenue, Milwaukee, Wisconsin 53202, (800) 792-2473, or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, New York 10010-3629, (800) 221-1037.